test altFunding OpportunitiesAward ManagementComliance Review and OversightEducation and TrainingTechnology Transfer
Office of Research and Technology Management
Promoting Research, Advancing Scholarship, Fostering Innovation
Identify Funding Oportunities Proposal Development Award Management
Compliance Review and Oversight Education and Training Technology Transfer


Welcome from the Vice President for Research

CWRU researchers are among the most distinguished in the world. We have 16 Nobel Laureates among current and former faculty and alumni, 4 members of the National Academies of Sciences, 7 members of the National Academy of Engineering, and 8 members of the Institute of Medicine. We also partner with artistic and cultural institutions on a broad range of projects that make important scholarly contributions in the humanities and social sciences.

Extraordinary research requires an outstanding infrastructure. Our Office of Research & Technology Management provides support to seek out grant funding, to facilitate industrial sponsorship, and to transfer university technologies to the marketplace. This is a place for people driven to make a difference, and our office exists to help them succeed.

Contact us. We want you to see what our campus can offer.

Dr. Suzanne Rivera

Research ShowCASE

Research ShowCASE + Intersections 2015 is almost here!

Please join us on Friday, April 17th from 9 AM to 3 PM in the Veale Convocation Center for our celebration of discovery, collaboration, and community.

For the first time we are offering a mobile app to help visitors better navigate the event. Go to Guidebook.com/g/ShowCASE from your iOS or Android device to download the app.


SpartaCOI is now available for 2014 Annual Outside Financial Interests Certification

Sparta COI Disclosure System

It is time for all full-time faculty and non-faculty investigators to complete the annual CWRU Outside Financial Interests Certification Form. CWRU Conflict of Interests Policy requires disclosure at least annually and the deadline for completion of the 2014 form is April 1, 2015.

Please visit our Conflict of Interests (COI) Committee website for more information, including a schedule of in-person assistance sessions and a user Guide for our new application, SpartaCOI.





Research Matters

Research Matters

Use the following link in order to view previous editions of Research Matters and Research News and Updates Research Matters Archive .




Latest News

Research Newsletter
May 14, 2015  

National Human Genome Research Institute (NHGRI)

The National Human Genome Research Institute (NHGRI) is soliciting grant applications for the support of Centers of Excellence in Ethical, Legal and Social Implications (ELSI) Research (CEERs). The CEER Program is designed to support the establishment of sustainable trans-disciplinary research teams with the expertise and flexibility to anticipate, conduct research on, and quickly address a range of cutting edge ethical, legal, and social issues related to genetics and genomics. The Program is intended to create new research opportunities that cross disciplinary boundaries among investigators in diverse fields, such as the genomic sciences, clinical research, clinical and health policy, ethics, law, the humanities, economics, political science, anthropology and other basic social sciences. In addition to conducting trans-disciplinary research, Centers will disseminate their research findings and engage in other activities that facilitate the utilization of their findings and deliberations in the development of research, health and public policies and practices regarding the use of genomic information and technologies. Finally, Centers will contribute to developing the next generation of ELSI researchers.

Letter of Intent Deadline: June 1, 2015 Application Deadline: July 15, 2015

For more information visit the NIH webpage.

 
Ferring Pharmaceuticals

Ferring Pharmaceuticals is pleased to announce that the Ferring Innovation Grants Portal is now open and accepting applications. The goal of the Ferring Innovation Grants program is to fund projects designed to identify novel drug targets that are:

  • For indications within their core therapeutic areas (Reproductive Health, Urology, Gastroenterology)

  • Addressable with peptides and/or proteins

  • Exploratory, discovery and/or preclinical in nature


The program will provide a limited number of grants in the amount of $50,000. The grants DO NOT carry indirect costs and are not renewable. Funding will not be provided for clinical studies, studies which require collection of patient biopsies or studies to develop small molecules. In all cases the intellectual property rights remain with the applicant.

Application Deadline: July 1st, 2015

For more information visit the Ferring Pharmaceuticals webpage.

 
Purchasing Computing Devices with Federal Funds under the New Uniform Guidance (2 CFR Parts 200.20 and 200.453)

Computing devices are machines used to acquire, store, analyze, process, and publish data and other information electronically and include accessories (or peripherals) for printing, transmitting and receiving, or storing electronic information. Computing devices costing less than $5,000 are not considered equipment and therefore are treated as supplies and materials. Therefore, if a computing device is to be acquired for use in the performance of a federal award, the computing device may be charged to the federal award provided that:

  • it is essential (i.e., necessary) to performing the work under the award, and
  • the cost is allocable and reasonable.
Determining whether a computing device is essential – The Principal Investigator should consider (and document) whether performing the work under the award without the computing device would be difficult and inefficient. An important measure of this is determining (and documenting) whether the anticipated cost of performing the work without the computing device is greater than the combined cost of performing the work plus the cost of acquiring the computing device.

Determining whether a computing device is allocable to a federal award – If a computing device is essential to and will benefit a federal award, it is allocable to that award. The cost may be allocated to a federal award even when its usage is not solely dedicated to it. However, the Principal Investigator should first consider the amount of benefit of the computing device to the project, and the cost should be allocated proportionally with a reasonable cost allocation methodology.

Determining whether the cost of a computing device is reasonable – The Principal Investigator must make an informed, prudent decision, taking into consideration not only the cost, but the utility, quality and value of the device to the project.

If a computing device is not essential to a federal award, it is not allocable (in whole or in part) as a direct cost to that award. In such cases, the computing device is considered to be a “general use” item and must be treated as an indirect cost expense (just like paper, pens and other general use supplies), and charged to an appropriate institutional funding source.

Please remember that all expenses charged to federal awards must conform to the cost principles specified in the OMB Uniform Guidance. Please consult with the Office of Research Administration if you should have any questions about whether you may charge a specific expense to federal funds.

 
FOIA Requests

CWRU researchers who receive requests for information that invoke the Freedom of Information Act (FOIA) should contact the Office of General Counsel. This should be done immediately so the extremely short deadlines under FOIA can be met. General Counsel can work with the faculty member to take steps to protect proprietary or confidential information from grants and protocols prior to the release of the requested information. Individual researchers should not release information without first consulting with the CWRU Office of General Counsel.

For more information, contact the Office of General Counsel at: http://www.case.edu/president/counsel/contactus.html.

 
Good Clinical Practice (GCP) Certification

Tuesday, June 2, 2015
8:00AM – 11:30 AM
Wolstein Research Building Auditorium, Room 1413


8:00 – 10:00 AM- GCP and PI Responsibilities:
This session will include discussions of the relationships between laws, regulations, guidelines, and standard operating procedures. Key obligations of sponsors, monitors and investigators and their inter-relationships will be described. Investigators completing the program will receive a GCP certificate that can be provided to sponsors.

10:15 - 11:30 AM- Ethical Considerations, Informed Consent and Financial Disclosure:
This session will include a brief historical perspective of ethical considerations in conducting clinical research. The elements and process for obtaining informed consent from potential study participants will be discussed and well as financial disclosure.

Registration is online at: http://research.case.edu/Education/OnlineCalendar.cfm.

 

If you have news or information that you wish to have included in this update, please send it via e-mail to Tracy Wilson-Holden at tracy.wilson-holden@case.edu no later than 5 pm on the Monday of the week that the update is to be distributed. If you know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe to Case Research News, email your request to Tora Williams at tora.williams@case.edu.

Please note: At the time of this transmission, all links functioned. However, Case Research News cannot guarantee that the information will not move or be deleted.